Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
European Urology
|
December 5, 2016
Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree
Richard J Sylvester, Steven E Canfield, Thomas B L Lam, et al.
European Urology
|
April 3, 2021
Shockwave Lithotripsy Versus Ureteroscopic Treatment as Therapeutic Interventions for Stones of the Ureter (TISU): A Multicentre Randomised Controlled Non-inferiority Trial
Ranan Dasgupta, Sarah Cameron, Lorna Aucott, et al.
European Urology
|
March 13, 2012
Systematic review of oncological outcomes following surgical management of localised renal cancer
Steven MacLennan, Mari Imamura, Marie C Lapitan, et al.
European Urology
|
December 29, 2015
Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus
Michael Lardas, Fiona Stewart, Duncan Scrimgeour, et al.
BJU International
|
April 1, 2021
Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
Yasmin Abu-Ghanem, Thomas Powles, Umberto Capitanio, et al.
European Urology
|
July 31, 2012
Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer
Steven MacLennan, Mari Imamura, Marie C Lapitan, et al.
European Urology
|
May 8, 2021
A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer
Thomas Van den Broeck, Daniela Oprea-Lager, Lisa Moris, et al.
European Urology
|
February 21, 2022
Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium
Katharina Beyer, Lisa Moris, Michael Lardas, et al.
European Urology
|
March 9, 2020
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review
Lisa Moris, Marcus G Cumberbatch, Thomas Van den Broeck, et al.
European Urology Oncology
|
January 11, 2021
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research
Anthony S Bates, Jennifer Ayers, Nikolaos Kostakopoulos, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
European Urology
|
December 5, 2016
Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree
Richard J Sylvester, Steven E Canfield, Thomas B L Lam, et al.
European Urology
|
April 3, 2021
Shockwave Lithotripsy Versus Ureteroscopic Treatment as Therapeutic Interventions for Stones of the Ureter (TISU): A Multicentre Randomised Controlled Non-inferiority Trial
Ranan Dasgupta, Sarah Cameron, Lorna Aucott, et al.
European Urology
|
March 13, 2012
Systematic review of oncological outcomes following surgical management of localised renal cancer
Steven MacLennan, Mari Imamura, Marie C Lapitan, et al.
European Urology
|
December 29, 2015
Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus
Michael Lardas, Fiona Stewart, Duncan Scrimgeour, et al.
BJU International
|
April 1, 2021
Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
Yasmin Abu-Ghanem, Thomas Powles, Umberto Capitanio, et al.
European Urology
|
July 31, 2012
Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer
Steven MacLennan, Mari Imamura, Marie C Lapitan, et al.
European Urology
|
May 8, 2021
A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer
Thomas Van den Broeck, Daniela Oprea-Lager, Lisa Moris, et al.
European Urology
|
February 21, 2022
Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium
Katharina Beyer, Lisa Moris, Michael Lardas, et al.
European Urology
|
March 9, 2020
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review
Lisa Moris, Marcus G Cumberbatch, Thomas Van den Broeck, et al.
European Urology Oncology
|
January 11, 2021
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research
Anthony S Bates, Jennifer Ayers, Nikolaos Kostakopoulos, et al.
Page
of 3